A. Rosolen et al., IN-VITRO AND IN-VIVO ANTITUMOR EFFECTS OF RETROVIRUS-MEDIATED HERPES-SIMPLEX THYMIDINE KINASE GENE-TRANSFER IN HUMAN MEDULLOBLASTOMA, Gene therapy, 5(1), 1998, pp. 113-120
Citations number
37
Categorie Soggetti
Biothechnology & Applied Migrobiology","Genetics & Heredity",Biology,"Medicine, Research & Experimental
Herpes simplex virus thymidine kinase gene (HSVtk) transfer together w
ith treatment with the prodrug ganciclovir (GCV) represents the most c
ommonly used suicide gene approach for the gene therapy of human centr
al nervous system malignancies. Despite encouraging results reported i
n clinical trials conducted in adults, very little is known about the
feasibility of this approach for the treatment of CNS tumors of childh
ood. We studied the effects of the HSVtk/GCV system on human medullobl
astoma cells in vitro and in vivo. The transfer of tk gene to medullob
lastoma cells was capable of mediating cell suicide in vitro and in vi
vo upon treatment with GCV, but the overall effect in vivo appeared to
be suboptimal. The relatively low sensitivity of the medulloblastoma
cells to viral infection and a limited bystander effect, coupled with
a low expression of connexin-43 protein, might partially explain these
results. Whether this is a peculiarity of the cell line studied or a
general characteristic of medulloblastoma remains to be determined. Th
ese findings should be taken into account for the future planning of g
ene therapy trials for human medulloblastoma.